A dangerous frenzy in the stockmarkets

Is Alibaba's record-breaking New York float a sign that investors are getting overexcited?

It can hardly be a coincidence, says Randall W Forsyth in Barron's, that advertisements for testosterone supplements are often shown on financial cable channels.

High testosterone levels instil the winner's effect', "a useful evolutionary tendency toward confidence for those heading into battle, as well as for successful traders".

But it also "eventually leads to hubris with the predictable results seen in 2008". The bullishness in the US stock-market is looking increasingly irrational.

Last week, the Chinese internet giant, Alibaba, the biggest initial public offering (IPO) or flotation in US history, soared on its first day of trading, jumping to a price/earnings ratio of 61.

Regardless of Alibaba's impressive growth potential, this looks very high, especially considering its dodgy corporate governance. Shareholder rights are so weak that the Hong Kong stockmarket would not allow the company to list there.

The US market is in the midst of a boom in flotations not seen since the dotcom bubble burst, says James Mackintosh in the FT. An IPO frenzy is a sign that "investors are overexcited".

What's more, adds Mackintosh, "leveraged loans are not just flashing red but have a wailing siren and a man walking in front waving a flag". These are loans for private-equity groups buying companies that already have a lot of debt.

More than a third of such loans this year were worth more than six times the target company's earnings. That's only slightly below the multiple seen at the peak of the credit bubble in 2007.

Moreover, a record 60% of loans are currently covenant-light', with less creditor protection than usual.

There are several other signs of irrational exuberance. Margin debt, whereby investors borrow money to play the stockmarket, has reached record levels. The share buyback boom, which has artificially inflated earnings per share, looks set to run out of steam, as we noted last week.

Finally, valuations are high. The market's forward price/earnings ratio of just under 16 is close to record levels. A far more reliable gauge, the cyclically adjusted price earnings ratio, looks extremely high (see next story).

In short, the market is looking extremely stretched just as the US Federal Reserve is set to reverse the liquidity spree of recent years by hiking interest rates.

Recommended

The top funds to invest in
Funds

The top funds to invest in

Investors continue to favour passive funds in April though figures reveal an actively managed money market fund also caught their eye. We look at wher…
3 May 2023
Cheap and cheerful or reassuringly expensive?
Sponsored

Cheap and cheerful or reassuringly expensive?

Many investors aim to pick up “cheap” shares. But cheap does not always mean good value, says Max King. Quality comes at a price.
21 Dec 2022
Profit from patience
Advertisement Feature

Profit from patience

Smart investors will reap the rewards by staying focused on the long-term, research from Alliance Trust shows.
9 Dec 2022
Share tips of the week – 9 December
Share tips

Share tips of the week – 9 December

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
9 Dec 2022

Most Popular

June’s NS&I Premium Bond prize draw - are you this month’s millionaire?
Savings

June’s NS&I Premium Bond prize draw - are you this month’s millionaire?

Two fortunate NS&I Premium Bond winners are now millionaires. Find out here if you’re one of them.
1 Jun 2023
The best one-year fixed savings accounts - June 2023
Savings

The best one-year fixed savings accounts - June 2023

You can now earn 5% on 1 year fixed savings accounts - the best rate seen in 14 years. We have all the latest rates available now.
2 Jun 2023
The top healthcare funds to buy
Investments

The top healthcare funds to buy

Increasingly rapid progress in drugs and healthcare technology makes these trusts top tips, says Max King.
1 Jun 2023